Construction and Effect Evaluation of Anticoagulation Management Model in Atrial Fibrillation
NCT05316870 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 380
Last updated 2022-04-07
Summary
Study types and hypotheses: multicenter randomized controlled trials. This study predicts that standardized anticoagulation management of atrial fibrillation in primary health care institutions can reduce the prevalence of atrial fibrillation stroke by 50%.
1. Formulation and revision of standardized anticoagulation management plan and process for atrial fibrillation in primary health care institutions.
Using the mature anticoagulation management model of atrial fibrillation for reference, based on the clinical data and disease management needs of patients with atrial fibrillation in five community health service centers in Xicheng District of Beijing. To formulate the anticoagulation management plan and process of atrial fibrillation suitable for grass-roots medical institutions. After the completion of the first draft of anticoagulation management plan and process, two rounds of multi-disciplinary experts were organized to demonstrate the feasibility and scientific nature of the first draft. Finally, based on the practice and effect evaluation of clinical application management, the scheme is revised and improved.
2. To evaluate the feasibility and clinical application effect of standardized anticoagulation management scheme and process for atrial fibrillation.
First of all, the baseline clinical database of patients with multicenter atrial fibrillation was established; secondly, patients with atrial fibrillation who met the entry criteria were randomly included in the trial group or control group and followed up for two years. The anticoagulation treatment rate, the incidence of bleeding and thromboembolic events, anticoagulation compliance rate and knowledge awareness rate of atrial fibrillation in the two groups were compared, and the effect of standardized anticoagulation management of atrial fibrillation in primary medical institutions was evaluated.
Conditions
Interventions
- BEHAVIORAL
-
Standardized anticoagulation management plan and process of atrial fibrillation in primary medical institutions
Compared with the current anticoagulation management service, we pay more attention to early initiation of anticoagulant therapy and long-term follow-up management.
- BEHAVIORAL
-
Conventional general practitioner management model
The current general practitioner anticoagulation management model was continued in the control group.
Sponsors & Collaborators
-
Exhibition Road Community Health Service Center of Xicheng District, Beijing, China
collaborator UNKNOWN -
Xinjiekou Community Health Service Center of Xicheng District, Beijing, China
collaborator UNKNOWN -
Guanwai Community Health Service Center of Xicheng District, Beijing, China
collaborator UNKNOWN -
Guannei Community Health Service Center of Xicheng District, Beijing, China
collaborator UNKNOWN -
Beijing Municipal Health Commission
lead OTHER_GOV
Principal Investigators
-
Xia J Wang, Master · FuXing Hospital, Capital Medical University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-09-04
- Primary Completion
- 2022-12-31
- Completion
- 2022-12-31
Countries
- China
Study Locations
More Related Trials
-
Risk Factors for Stroke or Systemic Embolism in Chinese Patients with Non-Valvular Atrial Fibrillation Registry
NCT05598632 ·Status: RECRUITING
-
Biomarkers of Atrial Fibrillation Complicated With Stroke Based on Proteomics and Metabolomics
NCT05181787 ·Status: UNKNOWN
-
Prospective Cohort Study of the Risk of Recurrent Atrial Fibrillation After Radiofrequency Ablation
NCT05638841 ·Status: RECRUITING
-
Multidisciplinary Team Approach to Prescribe Antithrombotic Therapy in Older People With Atrial Fibrillation
NCT04932603 ·Status: COMPLETED
-
Use of Anticoagulant, and Associated Factors of Anticoagulant Refusal Atrial Fibrillation Patients
NCT04062071 ·Status: UNKNOWN
-
Optimal Ablation Strategies for Persistent AF With HF
NCT07153718 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Discontinuation of Anticoagulations After Successful Catheter Ablation of Atrial Fibrillation
NCT06615596 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Atrial Fibrillation Patients Treated With Catheter Ablation
NCT05266144 ·Status: RECRUITING
-
Patient-reported Outcome Follow-up Based on the Northern Shanghai Community Chronic Disease Management System
NCT05511662 ·Status: UNKNOWN
-
CCC Project - Atrial Fibrillation
NCT02309398 ·Status: COMPLETED
-
Rhythm Evaluation for AntiCoagulaTion With COntinuous Monitoring
NCT01706146 ·Status: COMPLETED ·Phase: PHASE4
-
Catheter Ablation Versus Antiarrythmic Drugs for Atrial Fibrillation in China
NCT01341353 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of the Closed-loop Treatment Concept of Atrial Fibrillation in the Atrial Fibrillation Population
NCT05311137 ·Status: RECRUITING
-
Bi-atrial Versus Left Atrial Ablation for Patients With Rheumatic Mitral Valve Disease and Non-paroxysmal Atrial Fibrillation
NCT05021601 ·Status: RECRUITING ·Phase: NA
-
Chinese Atrial Fibrillation Registry
NCT06987825 ·Status: RECRUITING
-
Mhealth Application for anTicoagulation Care in Atrial Fibrillation
NCT03174093 ·Status: UNKNOWN ·Phase: NA
-
The Safety and Efficacy of Pulsed Field Ablation for Patients With Persistent Atrial Fibrillation Comorbid With HFpEF.
NCT07077811 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Promoting Atrial Fibrillation Screening in Primary Care
NCT06458829 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Catheter Ablation for Functional Mitral Regurgitation in Persistent Atrial Fibrillation: Development and Validation of a Predictive Model-A Multicenter Prospective Cohort Study
NCT07096219 ·Status: ENROLLING_BY_INVITATION
-
A New Approach for Catheter Ablation of Atrial Fibrillation
NCT05989321 ·Status: COMPLETED
-
Atrial Fibrillation with Heart Failure with Preserved Ejection Fraction: Treatment Strategies-Catheter Ablation Vs. Anti-Atrial Arrhythmia Drugs
NCT06740539 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Investigation of Specific Biomarkers in Patients With Atrial Fibrillation Who Undergo Interventional Treatment
NCT05170607 ·Status: UNKNOWN
-
Atrial Fibrillation Follow-up Investigation to Recover Memory and learnING Trial
NCT05374642 ·Status: COMPLETED ·Phase: NA
-
Risk Stratification Value of Biomarkers in Patients With Ventricular Arrhythmias
NCT05965375 ·Status: NOT_YET_RECRUITING
-
Dapagliflozin Evaluation on Atrial Fibrillation Patients Followed Cox Maze IV Procedure
NCT05816733 ·Status: RECRUITING ·Phase: PHASE4